Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) has 218 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 711,619 | 5.97% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 1,358,760 | 13.83% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | 223,363 | 6.82% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -308,360 | -45.95% | $0.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 0 | 1,734,964 | 29.71% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | -21,068 | -0.75% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 1,188 | 0.00% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 135,815 | 3.28% | $0.00 |
| Rosalind Advisors, Inc. | 31 Dec, 2025 | 0 | 315,934 | 17.59% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 378,595 | 10.13% | $0.00 |
| CenterBook Partners LP | 31 Dec, 2025 | 0 | 693,386 | 99.31% | $0.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 0 | 361,438 | 13.80% | $0.00 |
| Knott David M Jr | 31 Dec, 2025 | 0 | -45,000 | -4.43% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | -511,918 | -15.90% | $0.00 |
| Ishara Investments LP | 31 Dec, 2025 | 0 | 800,000 | 0.00% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | 1,705,636 | 293.59% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | 608,080 | 0.00% | $0.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 0 | 118,088 | 7.31% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -1,180,900 | -66.24% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | -227,034 | -12.64% | $0.00 |